BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35896309)

  • 1. Coagulation proteases and neurotransmitters in pathogenicity of glioblastoma multiforme.
    Tripathy S; Singh S; Banerjee M; Modi DR; Prakash A
    Int J Neurosci; 2024 Apr; 134(4):398-408. PubMed ID: 35896309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease signaling in tumor progression.
    Camerer E
    Thromb Res; 2007; 120 Suppl 2():S75-81. PubMed ID: 18023718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Coagulation Proteases and PARs (Protease-Activated Receptors) in Mouse Models of Inflammatory Diseases.
    Posma JJ; Grover SP; Hisada Y; Owens AP; Antoniak S; Spronk HM; Mackman N
    Arterioscler Thromb Vasc Biol; 2019 Jan; 39(1):13-24. PubMed ID: 30580574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-activated receptor signalling by coagulation proteases in endothelial cells.
    Rezaie AR
    Thromb Haemost; 2014 Nov; 112(5):876-82. PubMed ID: 24990498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of protease-activated receptors in the vascular system.
    Hirano K; Kanaide H
    J Atheroscler Thromb; 2003; 10(4):211-25. PubMed ID: 14566084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of neurotransmitters in glioblastoma multiforme-associated seizures.
    Joghataei MT; Bakhtiarzadeh F; Dehghan S; Ketabforoush AHME; Golab F; Zarbakhsh S; Ahmadirad N
    Int J Dev Neurosci; 2023 Dec; 83(8):677-690. PubMed ID: 37563091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.
    Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
    Cancer Metastasis Rev; 2015 Dec; 34(4):775-96. PubMed ID: 26573921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.
    Kuhn SA; Martin M; Brodhun M; Kratzsch T; Hanisch UK; Haberl H
    Neurol Res; 2014 Aug; 36(8):709-21. PubMed ID: 24620969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer.
    Arora P; Ricks TK; Trejo J
    J Cell Sci; 2007 Mar; 120(Pt 6):921-8. PubMed ID: 17344429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue factor, coagulation proteases, and protease-activated receptors in endotoxemia and sepsis.
    Pawlinski R; Mackman N
    Crit Care Med; 2004 May; 32(5 Suppl):S293-7. PubMed ID: 15118533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors.
    Yonamine CM; Kondo MY; Nering MB; GouvĂȘa IE; Okamoto D; Andrade D; da Silva JA; Prieto da Silva AR; Yamane T; Juliano MA; Juliano L; Lapa AJ; Hayashi MA; Lima-Landman MT
    Toxicon; 2014 Mar; 79():64-71. PubMed ID: 24412460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Endocannabinoid System Present in the Glioblastoma Tumour Microenvironment as a Potential Anti-Cancer Strategy.
    Dasram MH; Naidoo P; Walker RB; Khamanga SM
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors: contribution to physiology and disease.
    Ossovskaya VS; Bunnett NW
    Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protease-activated receptors: regulation of neuronal function.
    Saito T; Bunnett NW
    Neuromolecular Med; 2005; 7(1-2):79-99. PubMed ID: 16052040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
    van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
    Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of the postulated mechanisms linking cancer and thrombosis.
    ten Cate H; Falanga A
    Pathophysiol Haemost Thromb; 2008; 36(3-4):122-30. PubMed ID: 19176985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CNS macrophages and peripheral myeloid cells in brain tumours.
    Glass R; Synowitz M
    Acta Neuropathol; 2014 Sep; 128(3):347-62. PubMed ID: 24722970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptors in the brain: receptor expression, activation, and functions in neurodegeneration and neuroprotection.
    Luo W; Wang Y; Reiser G
    Brain Res Rev; 2007 Dec; 56(2):331-45. PubMed ID: 17915333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity.
    Perelroizen R; Philosof B; Budick-Harmelin N; Chernobylsky T; Ron A; Katzir R; Shimon D; Tessler A; Adir O; Gaoni-Yogev A; Meyer T; Krivitsky A; Shidlovsky N; Madi A; Ruppin E; Mayo L
    Brain; 2022 Sep; 145(9):3288-3307. PubMed ID: 35899587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.